1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Apokyn: new trials by email Literature Review of Apokyn trials Research Report on Apokyn
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist Safinamide (as add-on therapy) - Idiopathic Parkinson's Disease | Phase 3 | Completed | Newron Pharmaceuticals SPA | 679 | 2007-11-01 | 2013-10-29 |
Newron Pharmaceuticals SPA (1)
Argentina (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · Colombia (1) · Croatia (1) · Czechia (1) · Finland (1) · Germany (1) · India (1) · Italy (1) · Mexico (1) · Peru (1) · Poland (1)